Floatz logo

Bendamustine

Advanced or Metastatic Solid Tumor

BayerSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Advanced or Metastatic Solid Tumor cohort.

Asset / SponsorPhaseRating
Futibatinib
Taiho Pharmaceutical Co., Ltd.
Phase 2CCC
Inno-206
Bayer
Phase 1CC
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Bayer
Phase 1CC
(+)-VINCRISTINE
Taiho Pharmaceutical Co., Ltd.
Phase 1CC
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Bayer
Phase 1CC

View all 27 →

Same molecule, other indications

Bendamustine is also rated in:

mantle cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →